DE1954839A1 - Tetrazole derivatives - Google Patents
Tetrazole derivativesInfo
- Publication number
- DE1954839A1 DE1954839A1 DE19691954839 DE1954839A DE1954839A1 DE 1954839 A1 DE1954839 A1 DE 1954839A1 DE 19691954839 DE19691954839 DE 19691954839 DE 1954839 A DE1954839 A DE 1954839A DE 1954839 A1 DE1954839 A1 DE 1954839A1
- Authority
- DE
- Germany
- Prior art keywords
- tetrazole
- general formula
- carbon atoms
- carboxy
- benzoxazepin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
zurEingabevom JQ. Oktober 1909 Sch/ Name d. Anm. T.J. Smith & NepheW Ltd.for entering JQ. October 1909 Sch / Name d. Note TJ Smith & NepheW Ltd.
Tetrazolderivate.Tetrazole derivatives.
Die Erfindung betrifft Tetrazolderivate und ein Verfahren zu ihrer Herstellung.The invention relates to tetrazole derivatives and a method for their manufacture.
Die Erfindung betrifft Tetrazolderivate der allgemeinen Formel The invention relates to tetrazole derivatives of the general formula
in der R1 Wasserstoff, bis 6 Kohlenstoffatome aufweisendes Alkyl, bis 6 Kohlenstoffatome aufweisendes Alkoxy, Halogen oder Trifluormethyl bedeutet»in which R 1 is hydrogen, alkyl having up to 6 carbon atoms, alkoxy, halogen or trifluoromethyl having up to 6 carbon atoms »
Derivate der allgemeinen Formel I werden erfindungsgemäß in der Weise hergestellt, daß man eine Verbindung der allgemeinen FormelDerivatives of the general formula I are according to the invention in made in such a way that one can connect the general formula
3 34/30 -T-3 34/30 -T-
009819/1882009819/1882
i N-N i NN
II HII H
dehydratisiert, in der R1 die vorstehend angegebene Bedeutung hat.dehydrated, in which R 1 has the meaning given above.
Eine Dehydratation kann z.B. mittels Thionylchlorid durchgeführt werden.Dehydration can be carried out using thionyl chloride, for example will.
Die Verbindungen der allgemeinen Formel II sind neu und sind Gegenstand der Erfindung.The compounds of the general formula II are new and are the subject matter the invention.
Die Erfindung betrifft ferner ein Verfahren zum Herstellen der Verbindungen der allgemeinen Formel II, gemäß welchem man eine Verbindung der allgemeinen FormelThe invention also relates to a method for producing the Compounds of the general formula II, according to which a compound of the general formula
HI.HI.
hydrolysiert, in der R^ die vorstehend angegebene Bedeutung hat, und R1J und R, die Beudeutung wie Rt haben.hydrolyzed, in which R ^ has the meaning given above, and R 1 J and R, which have the meaning as R t .
Die Hydrolyse kann z.B. mittels einer 20#igen wässrigen Bfatriumhydroxydlösung durchgeführt werden.The hydrolysis can be carried out, for example, by means of a 20 # strength aqueous sodium hydroxide solution be performed.
3 54/30 -2-3 54/30 -2-
009819/1882009819/1882
-3*' 195A839-3 * '195A839
Die Verbindungen der allgemeinen Formel I können als Zwischenprodukte zur Herstellung der in der schwebenden Anmeldung S 34/25+ offenbarten substituierten Tetrazole verwendet werden, bei welchen es sich um Anaigetika und entzündungswidrige Mittel handelt.The compounds of general formula I can be used as intermediates for the production of the pending application S 34/25 + substituted tetrazoles disclosed which are anaigetics and anti-inflammatory agents can be used.
+ P 18 06 5^6.8+ P 18 06 5 ^ 6.8
Die Erfindung 1st in den folgenden Beispielen näher beschrieben.The invention is described in more detail in the following examples.
• Es wurden 44 g (0,20 Mol) 5-(2-Carboxyphenoxymethyl)-tetrazol mit 82 g (0,69 Mol) Thionylchlorid, das 2 Tropfen N,N-Dimethylformamld enthielt, in der Kälte behandelt. Nach einer Stunde wurde das Reaktionsgemisch langsam bis zur RUcklauftemperatur erwärmt und bei dieser Temperatur zwei Stunden gehalten, überschüssiges Thionylchlorid wurde entfernt und 31,2 g (785ε) eines braunen festen Stoffes erhalten, dessen Schmelzpunkt unter Zersetzung sich auf 128 - 133OC belief. Eine Kristallisation aus Benzol ergab das gewünschte Produkt mit einem Schmelzpunkt .von 135 - 1360C unter Zersetzung.• 44 g (0.20 mol) of 5- (2-carboxyphenoxymethyl) tetrazole were treated in the cold with 82 g (0.69 mol) of thionyl chloride containing 2 drops of N, N-dimethylformamide. After one hour, the reaction mixture was slowly heated to the return flow temperature and held for two hours at this temperature, excess thionyl chloride was obtained away and 31.2 g (785ε) of a brown solid substance having a melting point with decomposition at 128 - was 133 O C. Crystallization from benzene yielded the desired product having a melting point .of 135-136 0 C with decomposition.
C9H6N4O2 C 9 H 6 N 4 O 2
Die folgenden Verbindungen wurden aus in zweckmäßiger Weise substituierten Zwischenprodukten nach einer dem Beispiel I entsprechenden Methode hergestellt.The following compounds have been appropriately substituted from Intermediate products prepared by a method corresponding to Example I.
Beispiel II 7-Chlor-tetrazol(5j1-c)*-2,3,4,5-tetrahydro-1,4-benzoxazepln- Example II 7-chloro-tetrazole (5j1-c) * - 2,3,4,5-tetrahydro-1,4-benzoxazepln -
Weifle Nadeln aus Aceton, F = I9I - 192°CWhite needles made of acetone, F = 19I - 192 ° C
H NH N
gefunden : 45,91 2,35 23,1found: 45.91 2.35 23.1
erfordert: 45,68 2,13 23,68#Requires: 45.68 2.13 23.68 #
009819/1882 ~3'009819/1882 ~ 3 '
7-Methyl-tetrazol-(5j1-c)-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-methyl-tetrazole- (5j1-c) -2,3,4,5-tetrahydro-1,4-benzoxazepine-
5-on5-on
Farblose Stäbchen aus Aceton; P= 174 - 175°C.Colorless sticks made from acetone; P = 174-175 ° C.
C H NC H N
2 gefunden ϊ 55,82 3,85 25,74# erfordert: 55,55 3,73 25,92# 2 found ϊ 55.82 3.85 25.74 # requires: 55.55 3.73 25.92 #
8-Methoxy-tetrazol-(5J1-c)-2,3,4f5-tetrahydro-1,4-benzoxazepin-8-methoxy-tetrazole- (5 J 1-c) -2,3,4 f 5-tetrahydro-1,4-benzoxazepine-
Schwach gelblich gefärbte Nadeln aus Benzol; F= 186 - 187Pale yellow needles made from benzene; F = 186-187
C H NC H N
Die Herstellung der Zwischenprodukte, die noch nicht in der Literatur beschrieben wurden, ist nachstehend angegeben.The manufacture of intermediates, which is not yet in the literature is given below.
Präparat 1 5-(2-Carboxyphenoxymethyl)-tetrazolPreparation 1 5- (2-carboxyphenoxymethyl) tetrazole
Es wurden 8,55 g (0,029 Mol) 5-(2-Phenylcarbamoyl)-phenoxymethyl)· tetrazol in 75 ml einer 20#igen Natriumhydroxydlösung gelöst und fünf Stunden unter Rücklauf gekocht. Die gekühlte Lösung wurde mit 2 χ 50 ml Äthylacetat extrahiert und dann sorgfältig mit konzentrierter Salzsäure auf ein pH von 2 angesäuert, um einen weißen festen Stoff zu fällen. Der Feststoff wurde abfiltriert, mit Wasser gewaschen und getrocknet und 5,76 g (90$) eines Produktes mit einem Schmelzpunkt von 201 - 2020C erhalten. Eine Kristallisation aus Aceton:Wassergemisch (1:1 v/v) ergab einen8.55 g (0.029 mol) of 5- (2-phenylcarbamoyl) phenoxymethyl) tetrazole were dissolved in 75 ml of a 20% sodium hydroxide solution and refluxed for five hours. The cooled solution was extracted with 2 × 50 ml of ethyl acetate and then carefully acidified to pH 2 with concentrated hydrochloric acid to precipitate a white solid. The solid was filtered off, washed with water and dried, and 5.76 g (90 $) of a product having a melting point of 201 - 202 obtained 0C. Crystallization from acetone: water mixture (1: 1 v / v) gave a
S 34/30 -4-S 34/30 -4-
009819/1882009819/1882
weißen kristallinen festen Stoff mit einem Schmelzpunkt von 204 - 205°C.white crystalline solid with a melting point of 204 - 205 ° C.
CHNCHN
gefunden: 48,94 3,39 25,225gfound: 48.94 3.39 25.225g
erfordert: 49,09 3,66 25,requires: 49.09 3.66 25,
Präparat 2Preparation 2
5-(2-Carboxy-4-chlorphenoxymethyl)-tetrazol5- (2-carboxy-4-chlorophenoxymethyl) tetrazole
Hergestellt aus 5- ^~2-(Phenylcarbamoyl)-4-chlorphenoxymethyl_7Made from 5- ^ ~ 2- (phenylcarbamoyl) -4-chlorophenoxymethyl_7
tetrazol Weiße Nadeln nus Aceton; P = 210 - 2110C.tetrazole White needles with acetone; P = 210-211 0 C.
CHNCHN
C9H7ClN4O3 gefunden : 42,18 2,95 22,31$C 9 H 7 ClN 4 O 3 found: 42.18 $ 2.95 22.31
erfordert : 42,45 2,77 22,01$Requires: 42.45 $ 2.77 $ 22.01
Präparat 3Preparation 3
5-(2-Carboxy-4-methylphenoxymethyl)-tetrazol5- (2-carboxy-4-methylphenoxymethyl) tetrazole
Hergestellt aus 5- ^~2-(Phenylcarbamoyl)-4-methylphenoxymethyl7Made from 5- ^ ~ 2- (phenylcarbamoyl) -4-methylphenoxymethyl7
tetrazoltetrazole
Weiße Mikronadeln aus N,N-DimethyIformamid : Wasser (1:2 v/v); P = 188 - 1890CWhite microneedles made from N, N-dimethylformamide: water (1: 2 v / v); P = 188-189 0 C.
CHNCHN
gefunden : 51,37 4,15 24, erfordert: 51,28 4,30 23,92$found: 51.37 4.15 24, requires: 51.28 4.30 $ 23.92
3 34/30 -5-3 34/30 -5-
009819/1882009819/1882
->- ' 1954Ö39-> - '1954Ö39
Präparat 4Preparation 4
5-(2-Carboxy-5-methoxyphenoxymethyl)-tetrazol5- (2-carboxy-5-methoxyphenoxymethyl) tetrazole
Hergestellt aus 5-/~2-(3,4-Dichlorphenylcarbanioyl)-5-methoxyphenoxymethyl_7g tetrazol.Made from 5- / ~ 2- (3,4-dichlorophenylcarbanioyl) -5-methoxyphenoxymethyl_7g tetrazole.
Weißer kristalliner Stoff aus N,N-Din&hylformamid : Wasser (1:2 v/v); P = 220 - 221°C.White crystalline substance made from N, N-Din & hylformamide: water (1: 2 v / v); P = 220-221 ° C.
CHNCHN
gefunden: 48,06 4,0b 22,15#found: 48.06 4.0b 22.15 #
erfordert: 4ö,00 4,02requires: 4ö, 00 4.02
009819/1882009819/1882
Claims (1)
1 NN
1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5178168 | 1968-11-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1954839A1 true DE1954839A1 (en) | 1970-05-06 |
Family
ID=10461361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19691954839 Pending DE1954839A1 (en) | 1968-11-01 | 1969-10-31 | Tetrazole derivatives |
Country Status (4)
Country | Link |
---|---|
DE (1) | DE1954839A1 (en) |
FR (1) | FR2022378A1 (en) |
GB (1) | GB1238719A (en) |
SE (1) | SE363636B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102808A2 (en) * | 2001-06-14 | 2002-12-27 | Akzo Nobel N.V. | (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR |
US7307073B2 (en) | 2001-06-11 | 2007-12-11 | N.V. Organon | Benzoxazepines derivatives and their use as AMPA receptor stimulators |
-
1968
- 1968-11-01 GB GB1238719D patent/GB1238719A/en not_active Expired
-
1969
- 1969-10-30 SE SE1484969A patent/SE363636B/xx unknown
- 1969-10-31 FR FR6937457A patent/FR2022378A1/fr not_active Withdrawn
- 1969-10-31 DE DE19691954839 patent/DE1954839A1/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7307073B2 (en) | 2001-06-11 | 2007-12-11 | N.V. Organon | Benzoxazepines derivatives and their use as AMPA receptor stimulators |
US7504390B2 (en) | 2001-06-11 | 2009-03-17 | N.V. Organon | Benzoxazepine derivatives and their use as AMPA receptor stimulators |
WO2002102808A2 (en) * | 2001-06-14 | 2002-12-27 | Akzo Nobel N.V. | (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR |
WO2002102808A3 (en) * | 2001-06-14 | 2003-03-20 | Akzo Nobel Nv | (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR |
US7345036B2 (en) | 2001-06-14 | 2008-03-18 | N.V. Organon | (Pyrido/thieno)—[f]—oxazepine-5-one derivatives |
US7566778B2 (en) | 2001-06-14 | 2009-07-28 | N.V. Organon | (Pyrido/thieno)-[f]-oxazepine-5-one derivatives |
US8034804B2 (en) | 2001-06-14 | 2011-10-11 | N.V. Organon | (Pyrido/thieno)-[f]-oxazepine-5-one derivatives |
Also Published As
Publication number | Publication date |
---|---|
GB1238719A (en) | 1971-07-07 |
FR2022378A1 (en) | 1970-07-31 |
SE363636B (en) | 1974-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2359536C2 (en) | 2,6-diaminonebularin derivatives | |
DE2346034A1 (en) | ALPHA-METHYL-2-PHENYL-5-BENZOTHIAZOLYL ACID ACID | |
DE1954839A1 (en) | Tetrazole derivatives | |
DE1806546A1 (en) | Tetrazoles | |
DE1745780B2 (en) | 1-SULFONYLAETHYL-2-METHYL-5-NITROIMIDAZOLE AND THE METHOD OF MANUFACTURING IT | |
DE2033090C3 (en) | their manufacture | |
AT323154B (en) | PROCESS FOR THE PRODUCTION OF NEW 5-METHOXY-2-METHYLINDOL-3-ACETIC ACID DERIVATIVES AND OF THEIR SALTS | |
DE1695914C3 (en) | Process for the preparation of 1 di alkylaminoethyl 2 methyl 3 aryl 4 oxo 1,2,3,4 tetrahydroquinazolines | |
DE1745780C3 (en) | l-Sulfonyläthyl ^ -methyl-S-nitroimidazole and process for their preparation | |
DE2022746A1 (en) | Blood sugar lowering sulfonylaminopyrimidines and processes for their preparation | |
AT354432B (en) | METHOD FOR PRODUCING 3-INDOLYLESSIC ACIDS | |
DE2404924A1 (en) | ERGOLINE DERIVATIVES | |
AT296316B (en) | Process for the preparation of new benzodiazepine derivatives and their N-4-oxides | |
DE737931C (en) | Process for the preparation of 2,4-diaminochinazoline | |
DE2218248C3 (en) | Picolinic acid dithiocarbamates | |
DE1493619C (en) | Process for the preparation of 3- (3,4-dihydroxyphenyl) -2-methylalanine | |
DE1620054C (en) | Process for the preparation of quinolindenvates and drugs containing these compounds excretion from 1470047 | |
DE2131158A1 (en) | Benzodiazepine derivatives | |
AT211823B (en) | Process for the preparation of new aryloxyacetic acid amides | |
DE1545901C (en) | Process for the preparation of 2-mercaptoimidazole derivatives and their salts | |
DE1620395A1 (en) | Process for the preparation of cycloheptimidazolinium halides | |
DE1135478B (en) | Process for the preparation of 3, 5-dioxo-1, 2, 4-triazolidines | |
DE1111200B (en) | Process for the preparation of 1, 2, 4-Benzothiadiazin-1, 1-dioxyden | |
DE2429561A1 (en) | PROCESS FOR THE PRODUCTION OF SUBSTITUTED AMINOPHENOLS | |
CH535783A (en) | Pyrimidine ester derivs - hypnotics and sedatives esp 2,4-bis morpholino-and thiamorpholino-5-carboxy pyrimidine esters |